ME1 — Melodiol Global Health Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$0.01m
- AU$8.96m
- AU$19.60m
Brief: Melodiol Global Health Ltd Qtrly Unaudited Revenue A$7.5 MLN, Up 265% Pcp
Brief: Melodiol Global Health Received Firm Commitments To Raise A$1M
Brief: Melodiol Global Health Seeks Trading Halt
Brief: Melodiol Global Health Says Circa A$7.5 Mln In Unaudited Revenue Achieved In Q3
Brief: Melodiol Global Health Says Mernova's Q3 Revenue A$1.85 Mln
Australia's Melodiol Global jumps on Canadian unit's new orders, strong sales
Brief: Melodiol Global Health Says Mernova Maiden Alberta Po And Revenue Update
Brief: Melodiol Global Health Says Creso Impactive Signed Partnership Agreement With Tcu Horned Frogs
Brief: Melodiol Global Health Ltd Says On Track To Deliver Further Revenue Growth In Q3 2023
Brief: Melodiol Global Health Posts HY Net Loss Attributable Of A$28.3 Million
Brief: Melodiol Global Health Announces Capital Raising Totalling A$1.4M
Brief: Melodiol Global Health Seeks Trading Halt
Brief: Melodiol Global Health Secures Non-Binding LOI With Panacea Life Sciences
Australia's Melodiol Global Health gains on improved qtrly revenue
Brief: Melodiol Global Health Says Melodiol Posts A$1.6M In Q3 CY2023 In New Revenue
Brief: Melodiol Global Health Says Qtrly Unaudited Net Sales For Combined Melodiol Of A$4.74M
Brief: Creso Pharma Signs LOI To Import Licensed MDMA And Psilocybin Treatments To Australia
Brief: Creso Pharma Says Unit Entered Consulting Agreement With Canndelta Inc
Brief: Creso Pharma Secures Commitments To Raise A$2.5M